THE INDIAN PHARMACIST • ACADEMIC & CLINICAL REFERENCE PLATFORM Principal Reference: Indian Pharmacist Desk Reference — Edition 2.7 (2026–27)

THE INDIAN PHARMACIST

Learn. Explore. Practise. Excel.

An open-access academic and clinical pharmacy knowledge platform for India's practising pharmacists, D.Pharm, B.Pharm and Pharm.D students, and GPAT & Drug Inspector aspirants—bringing together 270 structured 4-zone medicine monographs, 51 curriculum chapters, 13 clinical calculators, Indian statutory schedules, and 18 scientific visual plates.

Explore Medicine Library (270 Monographs) → Explore Pharmacy Calculators (13 Tools)

Founded & authored by Tejas Chandrakant Nartam (Founder, Creator & Principal Author) • About & Editorial Standards ↓

270 MEDICINE MONOGRAPHS CHAPTERS 03–12

Complete 270 canonical monographs ([3.1]–[12.38]) with 4 clinical zones, Indian schedules, and transparent review-status disclosures.

51 ACADEMIC CHAPTERS 5 CORE DOMAINS

Structured Pharmacology, Pharmaceutics, Medicinal Chemistry, Pharmacognosy, and Hospital Pharmacy aligned with PCI syllabi.

13 CLINICAL CALCULATORS DETERMINISTIC

Cockcroft–Gault CrCl, Paediatric Clark/Young/BSA dosing, Alligation Alternate, Stock Dilution (C1V1 = C2V2), Isotonicity, and PK simulators.

INDIAN LAW & VISUAL ATLAS 16 LAWS • 18 PLATES

Drugs & Cosmetics Act 1940, Schedules C–X, Pharmacy Act 1948, NPPA DPCO 2013, and 18 interactive clinical diagrams.

📌 Quick Access: Select any medicine or chapter to view recent items & saved bookmarks locally in your browser.

Editorial Standards & Review Status Breakdown (28 Verified • 241 Handbook-Source • 1 Specialist Review) ↓

Structured Subject Discovery • Academic & Professional Pathways

Explore by Subject

Select any foundational discipline below to open its dedicated reference workspace or jump to its active tools.

PK LAB ACTIVE

1. Pharmacology

General pharmacology, dose-response receptor kinetics, autonomic & cardiovascular pharmacology, chemotherapy, and one-compartment clinical pharmacokinetics (Cmax, Tmax, AUC, t1/2).

Ch 02–12 & Atlas Plates

COMPENDIAL CORE

2. Pharmaceutical Sciences

Physical pharmaceutics, modified-release dosage form engineering (SR/ER/EC matrix rules), biopharmaceutics, medicinal chemistry SAR, pharmacognosy, and Indian Pharmacopoeia (IP) QA/QC standards.

IP Standards & Ch 20

ATLAS DIAGRAMS

3. Anatomy and Physiology

Organ-system physiology underlying drug action: renal nephron tubular transport (PCT, Loop of Henle, DCT, Collecting Duct), RAAS cascade, cardiac action potentials, and HPT endocrine feedback.

Atlas Plates I–V

ICMR AMSP

4. Microbiology

Bacterial cell-wall peptidoglycan (PBPs), 30S/50S ribosomal and DNA gyrase antimicrobial targets, moist/dry heat sterilization validation (F0 & D-value), endotoxin testing, and ICMR AWaRe stewardship.

Ch 08 & Sec 8.15

4 PREVIEW • 270 MAPPED

5. Medicine Knowledge

Structured 4-Zone, 12-Section generic medicine profiles covering indications, chronopharmacology, mechanism, KDIGO renal/hepatic adjustments, interactions, OPD counselling, and Schedule status.

Ch 03–12 (135 Paired Pages)

16 STATUTORY RECORDS

6. Indian Pharmacy and Regulations

Drugs and Cosmetics Act 1940, Drugs Rules 1945 (Schedules C, C1, G, H, H1, J, M, P, X & Forms 19–21B), Pharmacy Act 1948, PPR 2015, and DPCO 2013 essential medicine ceiling prices.

Ch 17 & Register D.7

Core Sciences Reference Matrix • Handbook Chapters 02, 03, 08 & 20

High-Yield Receptor, Physiological & Compendial Reference Summary

Core Discipline	Primary Receptor / Target / Standard	Representative Drug / Compendial Rule	Clinical & Exam Significance
Cardiovascular & Autonomic Pharmacology	L-Type Ca²⁺ (Cav1.2), AT₁, β₁/β₂, α₁A	Amlodipine [3.1], Telmisartan [3.11], Metoprolol [3.15], Tamsulosin [12.1]	DHP-CCBs selectively dilate peripheral arterioles; α₁A blockade relaxes prostatic smooth muscle (counsel on first-dose orthostasis & cataract IFIS).
Biopharmaceutics & Clinical PK	Bateman 1-Compartment & Michaelis-Menten	First-Order (t1/2 = 0.693/ke) vs Zero-Order Saturation (Phenytoin [11.13])	In linear PK, doubling dose doubles Cmax and AUC while Tmax and t1/2 stay constant; Phenytoin CYP2C9/2C19 saturates near 10–20 mcg/mL.
Renal Physiology & Diuretics	NKCC2 (TAL), NCC (DCT), ENaC / MR (CD), SGLT2 (PCT)	Furosemide/Torsemide, Chlorthalidone, Spironolactone, Dapagliflozin	Loop diuretics remain effective at eGFR < 30 mL/min; monitor K+ and Na+ closely and apply 'SAD-MANS' pause during acute dehydration.
Pharmaceutical Microbiology & IP QA	PBPs (Cell Wall), 30S/50S, Moist Heat 121°C × 15 min	Amoxicillin [8.1] (ACCESS), Azithromycin (WATCH), Colistin (RESERVE)	Beta-lactams exhibit time-dependent killing (fT > MIC); Indian Pharmacopoeia storage defines Cold Place (2°C–8°C) vs Cool Place (8°C–25°C).

Section 08 Flagship Tools • Deterministic Mathematical Engines

Pharmacy Calculator Workbench

Audited step-by-step clinical and compounding calculators with physiological boundary checks, unit conversions, and explicit safety notices.

21/21 CALCULATOR TESTS PASS EDUCATIONAL REFERENCE — DO NOT PRESCRIBE

TOOL A • RENAL PK VERIFIED

Creatinine Clearance (Cockcroft-Gault)

Adult CrCl (mL/min) using ABW, Devine IBW, or Obesity AdjBW (0.4 factor) with cm/in conversion.

TOOL B • COMPOUNDING VERIFIED

Alligation Alternate Calculator

Two-strength blending proportions, zero-concentration diluent support, and physical solute mass balance.

TOOL C • DISPENSING VERIFIED

Stock Dilution (C₁V₁ = C₂V₂)

Concentrated stock volume (V₁), cross-unit conversion (% w/v ↔ mg/mL), and diluent Q.S.

A. Adult Creatinine Clearance (Cockcroft & Gault, 1976)

ID: calc-cg-crcl

Age (Years) [18–110 yr]

Biological Sex Coefficient

Body Weight (kg) [20–300 kg]

Serum Creatinine S_cr (mg/dL) [0.2–20]

Explicit Weight-Selection Assumption

Section 03 Medicine Knowledge Library • Stage 2A 21-Section & 3-Audience Reference System

Searchable Generic Medicine Knowledge Library

Serving practising pharmacists, pharmacy students, and GPAT / Drug Inspector aspirants from one unified dataset. Features all 270 accessible 21-section and 4-zone medicine monographs ([3.1] through [12.38], plus separated [App-B.1] Emergency Adrenaline Module) across 10 canonical chapters and 22 therapeutic categories mapped to Indian Pharmacist Desk Reference — Professional Edition 2.7 (2026–27).

Mandatory Educational & Review Governance Disclaimer: Educational reference material. Content awaiting independent clinical or regulatory review must not be treated as independently verified prescribing or legal guidance. (Review Status Breakdown: 28 Verified Baseline Educational • 241 Edition 2.7 Handbook-Source Awaiting Clinical Review • 1 Specialist Clinical Review Pending [[11.13] Phenytoin] • 222 Awaiting Independent Regulatory Schedule Verification).

Editorial & Clinical Content Governance Classification System (Schema v2.0 • 21 Standard Sections): Source Attribution + Independent Verification

1. HANDBOOK SOURCE CONTENT 2. VERIFIED EDUCATIONAL / REVIEWED 3. DEMONSTRATION DATA 4. AWAITING / PENDING CLINICAL REVIEW 5. AWAITING / PENDING REGULATORY REVIEW

Search Generic, Synonym, Brand, Class, or Keyword

Edition 2.7 Chapter & Therapeutic Category (10 Chapters • 22 Categories • 270 Monographs)

Pharmacological Class

Safety Tier

Review Status

Alphabetical Generic Index (A–Z Browsing):

Browse All 15 Therapeutic Categories (4 Active Pilot Categories • 11 Stage 2B Expansion Categories)

Section 10 Visual Learning Library • Precision Scientific Vector Diagrams

Oral One-Compartment Pharmacokinetic Concentration-Time Profile

Click or press Enter on any parameter hotspot (C_max, T_max, AUC, t_1/2, or Therapeutic Window) to inspect its governing equation and exam significance.

Simulate Elimination Kinetics (k_e):

Handbook Visual Clinical Atlas • Vector Mechanism Schematics

Selected Scientific Mechanism Diagrams (Nephron & Antimicrobial Targets)

HANDBOOK ATLAS PLATES III & FIG 8.1

STAGE 2B • SCIENTIFIC VISUAL LEARNING ATLAS (ANATOMY • PHARMACOLOGY • MOLECULAR MECHANISMS • 3D DEMOS)

Scientific Visual Learning Atlas (32 Annotated Plates • 4 Collections • Interactive 3D-Style Canvas Demos & Rendered Visuals)

Showing 32 of 32 Verified Scientific Atlas Plates

Browse by Atlas Collection:

Search Visual Atlas (Anatomy, System, Medicine, Mechanism):

Filter by Scientific Discipline Category:

Drug-Specific Mechanism Collection • Pharmacological Mechanisms

Flagship Demo 1: Amlodipine — L-Type Calcium Channel (Cav1.2) Blockade

Vascular Smooth Muscle Sarcolemma & Peripheral Arteriolar Resistance Vessels

Select Atlas Plate (32):

Default High-Resolution 3D Render (Click Rotate or Launch 3D Model)

Technical Implementation Note: Default visuals are pre-rendered scientific illustrations (WebP). Interactive rotation/zoom uses a custom HTML5 2D Canvas geometric projection renderer (Euler rotation & painter's Z-sorting — not Three.js or WebGL) for universal offline and embedded-preview compatibility. Use attribution: Tejas Chandrakant Nartam (Ed. 2.7, v2.7.4).

Step-by-Step Mechanism & Labelled 3D Structure Hotspots:

ATLAS PLATE III PREVIEW • RENAL PHYSIOLOGY VECTOR SVG

Nephron Tubular Transport & Diuretic Site-of-Action Map

Clinical Pearl (Handbook Ch 03 & Plate III): Thiazide diuretics lose efficacy when eGFR < 30 mL/min (except Chlorthalidone/Metolazone in select protocols), whereas Loop diuretics acting on luminal NKCC2 retain natriuretic efficacy in advanced CKD.

FIGURE 8.1 PREVIEW • MICROBIOLOGY & CHEMOTHERAPY VECTOR SVG

Bacterial Cellular Targets & ICMR AWaRe Antimicrobial Classes

Stewardship Pearl (Handbook Sec 8.15 p. 112): Under ICMR AMSP guidelines, prioritize ACCESS group beta-lactams (such as Amoxicillin [8.1]) for routine community infections and preserve Schedule H1 WATCH / RESERVE agents.

PATHWAY A • STATUTORY REFERENCE Primary Legal & Licensing Reference (Distinguished from Pathway B: Competitive Exam Practice below)

Section 07 Jurisprudence Explorer • Statutory Law vs. Institutional Policy

Indian Pharmacy & Statutory Regulations Explorer

Search and filter 16 verified records from the Drugs and Cosmetics Act 1940, Drugs Rules 1945 (Schedules C, C1, G, H, H1, J, M, P, X & Forms 19–21B), Pharmacy Act 1948, PPR 2015, and DPCO 2013.

Search by Schedule Letter, Form Number, Section, or Keyword

Filter by Governance Status

PATHWAY B • COMPETITIVE EXAM PREPARATION Active Recall, Option-by-Option Statutory Rationale & Exam Syllabus Mapping

Section 09 Competitive Examination Preparation Hub

Drug Inspector, GPAT & Government Pharmacist Exam Readiness

High-yield statutory & pharmacological question bank with option-by-option verification rationales and browser-local progress storage.

VERIFIED_EDUCATIONAL QUESTION

FEATURED HIGH-YIELD MCQ • ID: mcq-di-gpat-001

A retail community pharmacy licensed in Forms 20 and 21 dispenses Cefixime tablets (a drug specified in Schedule H1 of the Drugs Rules, 1945) against the prescription of a Registered Medical Practitioner. Under Rule 65 and Rule 97 of the Drugs Rules, 1945, which of the following combination of statutory requirements is MANDATORY for this supply?

Indian Competitive Pharmacy Exam Blueprint Matrix

SYLLABUS MAP

Our curriculum modules map directly to the core subject weightages tested in UPSC / State PSC Drug Inspector exams, GPAT, and AIIMS / ESIC / RRB / CGHS Pharmacist recruitments:

Examination Stream	Primary High-Weightage Domains	Linked Platform Tool
UPSC & State PSC Drug Inspector	Drugs & Cosmetics Act 1940, Schedules C/G/H/H1/M/X, Forms 19–21B, Pharmacology, QA/QC	Section 07 Explorer
GPAT (Graduate Pharmacy Aptitude Test)	Biopharmaceutics & PK (Cmax, Tmax, AUC, t1/2), Alligation/Dilution, Pharmacology, Med Chem	Section 08 & 10 PK
AIIMS / ESIC / RRB / CGHS Pharmacist	Dispensing Pharmacy, Posology & Renal Dosing Principles, Hospital Pharmacy, Drug Store Laws	Section 08 Workbench

Stage 5 Exam Engine Expansion Notice:

Stage 1.5 provides the verified single-question rationale engine and browser-local progress storage. Full topic-wise timed practice sets are scheduled for Stage 5.

Sections 01, 11 & Handbook Chapters 01, 13, 16, 20

Pharmacy Practice Protocols & Printable Reference Resources

Evidence-based OPD dispensing workflows, oral modified-release safety rules, and print-ready study handouts.

Resource Series Authored & Directed by Tejas Chandrakant Nartam • Indian Pharmacist Desk Reference Ed. 2.7 (2026–27) • Release v2.7.4

HANDBOOK CH 01 • PAGE 11 HANDBOOK SOURCE

7-Step OPD Prescription Screening

1. Patient Identity & Age/Weight: Verify adult vs paediatric/geriatric status.
2. Diagnosis & Indication Match: Confirm therapeutic appropriateness.
3. Generic Name & LASA Check: Apply Tall-Man lettering verification.
4. Strength, Release Profile & Dose: Distinguish IR vs SR/XR/PR/EC.
5. Organ Function & Interactions: Screen eGFR/CrCl and CYP/P-gp pairs.
6. Chronotherapy & Food Relation: Label pre-meal vs with-meal timing.
7. Teach-Back Counselling: Confirm patient comprehension at counter.

HANDBOOK CH 20 • PAGE 209 MEDICATION SAFETY

Oral 'Do-Not-Crush' Formulation Rules

Enteric-Coated (EC / DR): Pantoprazole, Esomeprazole, Rabeprazole, Bisacodyl, Enteric Aspirin (acid labile or gastric irritant — never crush).
Sustained / Prolonged Release (SR / XR / PR): Metformin SR ([4.1]), Nifedipine SR, Diltiazem CD, Sodium Valproate CR (crushing causes fatal dose dumping).
Cytotoxic / Teratogenic Tablets: Methotrexate, Finasteride, Dutasteride, Mycophenolate (powder aerosolization/skin hazard).
Sublingual / Orally Disintegrating: Nitroglycerin SL, Ondansetron MD (engineered for rapid mucosal absorption).

APPENDIX A.2 • PAGE 213 HANDBOOK SOURCE

'SAD-MANS' Acute Sick-Day Protocol

Counsel patients to seek medical review regarding temporary medication pause during acute dehydrating illness (severe vomiting/diarrhoea/fever):

S — Sulfonylureas (Glimepiride, Gliclazide: hypoglycaemia)
A — ACE Inhibitors (Ramipril, Enalapril: acute kidney injury)
D — Diuretics (Furosemide, Thiazides, Spironolactone)
M — Metformin ([4.1]: lactic acidosis risk in AKI)
A — ARBs (Telmisartan, Losartan: efferent constriction)
N — NSAIDs (Diclofenac, Ibuprofen: afferent constriction)
S — SGLT2 Inhibitors (Dapagliflozin: euglycaemic DKA)

Print-Ready Study Sheets & Stage 1.5 Reference Packages

Use your browser's Print command (Ctrl+P) on any internal reference page to generate clean A4 study sheets via our built-in @media print stylesheet.

Complete 12-Section Platform Architecture • Governance & Syllabus Map

Twelve Academic & Professional Curriculum Pillars

Filter by curriculum division or inspect any pillar's sub-modules, verification status, and official statutory citations.

OFFICIAL PUBLISHING DIVISION • THE INDIAN PHARMACIST FREE PUBLIC EDUCATIONAL RELEASE — BOOKSTORE CATALOGUE PREVIEW

Founder, Creator & Principal Author: Tejas Chandrakant Nartam

Official Publications — Purchase Facility Coming Soon

Explore the official publication catalogue authored by Tejas Chandrakant Nartam, featuring the flagship Indian Pharmacist Desk Reference — Professional Edition 2.7 (2026–27) and forthcoming professional pharmacy reference compendia. Direct online ordering for Printed (Hardcover & Paperback) and Digital PDF editions will open upon completion of merchant onboarding.

100% Free Educational Access: All 270 Medicine Monographs, 51 Academic Chapters, 13 Clinical Calculators, 3D/2D Visual Atlas & 67 Exam MCQs are permanently free to read and use on this platform.

Public Release Status

Release Classification: v3.1.1 PUBLIC LAUNCH

Educational Platform: 100% FREE ACCESS

Bookstore Catalogue: PREVIEW ONLY

Purchase Facility: COMING SOON

1. Official Publication Catalogue 2. Forthcoming Educational Series 3. Publishing & Reader Governance Policies

Official Author Catalogue • Verified Specifications & Genuine Covers

Publications by Tejas Chandrakant Nartam

Official publication specifications and format editions (Printed & Digital PDF). Online ordering coming soon.

Scalable Catalogue Pipeline • Future Releases

Forthcoming Educational & Competitive Examination Publications

IN EDITORIAL PREPARATION

Publishing & Reader Governance

Terms, Privacy, Fulfilment Overview, Digital Licence & Educational Disclaimer

Official Reader & Platform Governance

Section 12 • Founder Recognition, Intellectual Ownership & Publication Governance

About the Founder, Creator & Principal Author

An independent educational initiative conceived, founded and developed under the direction of Tejas Chandrakant Nartam, Pharmacist and Author.

Publication Metadata & Version History ↓ Explore Desk Reference Monographs → Footer Attribution & Disclaimer ↓

TCN

Founder • Creator • Principal Author

TEJAS CHANDRAKANT NARTAM

Tejas Chandrakant Nartam

Pharmacist | Founder & Creator | Principal Author

Pharmacist | Creator of The Indian Pharmacist | Author

Author of:

Indian Pharmacist Desk Reference — Professional Edition 2.7 (2026–27)

Author-compiled 256-page clinical and regulatory pharmacy reference handbook containing 270 generic medicine monographs, 20 therapeutic chapters, 4 clinical appendices, and 18 multi-panel clinical illustrations.

Authorship & Development Attribution:

Concept, project direction, editorial ownership and authorship: Tejas Chandrakant Nartam. Developed with AI-assisted research, design and software development support.

Founder's Professional & Educational Statement

"The Indian Pharmacist is an independent educational initiative created to make pharmaceutical sciences, medicine knowledge, pharmacy practice and Indian pharmacy regulations more accessible through structured learning, scientific illustrations and practical educational resources."

Educational Mission & Platform Objectives

Conceived, founded and directed by Tejas Chandrakant Nartam, THE INDIAN PHARMACIST (Learn. Explore. Practise. Excel.) unifies author-provided compendial scholarship from the Indian Pharmacist Desk Reference — Professional Edition 2.7 (2026–27) with independently verified pharmacopoeial, statutory, and clinical learning modules for four core audiences:

1. Practising Pharmacists Structured generic medicine reference, dosage forms, dispensing safety checks, interactions, storage, and OPD patient counselling.

2. Pharmacy Students Mechanism of action deep-dives, anatomical and molecular visual learning, pharmacokinetics, and PCI-aligned core sciences.

3. Pharmacy Educators Evidence-grounded teaching diagrams, deterministic calculation workbenches, and printable academic reference handouts.

4. Drug Inspector & GPAT Aspirants Drugs & Cosmetics Act 1940 jurisprudence, Schedules & Forms explorer, comparative drug tables, and high-yield exam practice.

Phase 2 • Intellectual Property & Publication Governance

Official Publication Metadata, Content Classification & Version History

RELEASE: STAGE 2C (v2.7.4 • NOV 2026)

Platform Title & Tagline THE INDIAN PHARMACIST Learn. Explore. Practise. Excel.

Founder & Principal Author Tejas Chandrakant Nartam Pharmacist | Founder & Creator | Principal Author

Principal Source Publication Indian Pharmacist Desk Reference Professional Edition 2.7 (2026–27) • 256 pp.

Edition & Revision Dates Edition 2.7 Reference Release (v3.1.4) Published: Nov 2026 • Updated: 2026-11-05

Strict 5-Category Content Origin & Review Status Classification (Zero Silent Modification Rule)

Handbook source text is never silently altered; all records explicitly declare their origin and independent clinical/regulatory review status:

1. HANDBOOK SOURCE Original author-provided text & page citations from Desk Reference Ed. 2.7 (2026–27).

2. VERIFIED EDUCATIONAL Independently cross-checked against IP 2026, NLEM 2022, CDSCO, or KDIGO/ICMR guidelines.

3. WEBSITE-ONLY MODULE Interactive calculators, 32-plate Visual Atlas explanations, and active-recall study tools.

4. DEMONSTRATION / SIM Synthetic PK concentration-time Bateman curve and interactive 3D-style canvas models.

5. PENDING REVIEW Explicitly flagged where compendial/formulary reconciliation is pending (e.g., [11.13] Phenytoin IV).

Release / Version	Release Date	Lead Architect & Principal Author	Key Academic, Technical & Governance Milestones
Stage 1.0 (v1.0.0)	2026-11-03	Tejas Chandrakant Nartam	Initial platform baseline, 3 deterministic calculators (Cockcroft-Gault, Alligation, Dilution), Bateman PK curve, 16 statutory records, and 4 pilot monographs.
Stage 1.5 (v1.5.0)	2026-11-04	Tejas Chandrakant Nartam	Premium editorial redesign, 8-item navigation with mega-menus, 7-route SPA architecture, internal page shell, and GPU-safe preview stabilisation.
Stage 2A (v2.1.0)	2026-11-04	Tejas Chandrakant Nartam	21-Section Medicine Knowledge Library architecture, 3 connected audience views (Pharmacist, Student, Exam), synonym search, and side-by-side comparison.
Stage 2B (v2.7.0)	2026-11-04	Tejas Chandrakant Nartam	Global typography & A−/A/A+ font accessibility, bottom-footer disclaimer, 32-plate Scientific Visual Learning Atlas, 4 Flagship Demos, and 30 complete monographs.
Stage 2C (v2.7.4 • Current)	2026-11-05	Tejas Chandrakant Nartam	Permanent Founder & Principal Author recognition across homepage/profile/footer/exports, IP & version governance, honest 3D-style canvas labelling audit, and 30-monograph QA audit.

Editorial Governance, Review Transparency & Legal Disclosures

Editorial Methodology, Clinical Review Policy & Database Governance

Release v3.1.4 • Evidence Cut-Off: 2 November 2026

1. Editorial Methodology & Primary Compendia

Every medicine monograph and academic chapter on The Indian Pharmacist is structured under the editorial direction of Tejas Chandrakant Nartam (Founder, Creator & Principal Author) from the Indian Pharmacist Desk Reference — Professional Edition 2.7 (2026–27) and aligned with the Indian Pharmacopoeia (IP 2022/2026), National List of Essential Medicines (NLEM 2022), National Formulary of India (NFI 7th Ed.), Drugs and Cosmetics Act 1940 & Rules 1945, and Pharmacy Council of India (PCI) curriculum frameworks.

2. Honest Review-Status Governance (270 Monographs)

To uphold clinical transparency, each of the 270 canonical monographs ([3.1]–[12.38]) carries an explicit review-status disclosure:

28 Verified Baseline Monographs: Independently cross-checked against IP / NLEM 2022 / CDSCO reference parameters.
241 Handbook-Source Monographs: Hydrated from Edition 2.7 and marked Awaiting Independent Clinical Review.
1 Specialist PK Review Flagged Record: [11.13] Phenytoin (flagged for specialist narrow-therapeutic-index Michaelis–Menten review).
222 Regulatory Schedule Records: Marked Awaiting Independent Regulatory Schedule Verification (48 verified).
1 Supplementary Emergency Module: [App-B.1] Adrenaline (maintained separately from the 270 primary count).

3. Corrections, Feedback, Privacy & Educational Disclaimer

Corrections Policy: Pharmacists, faculty, and clinicians may submit compendial or statutory errata with primary IP/NLEM/CDSCO citations to editorial@theindianpharmacist.com. Verified errata are logged in the version register.

Privacy & Local Storage: No account creation or personal data submission is required. Bookmarks, recently viewed medicines, and reading preferences are stored strictly in your local browser storage.

Educational Disclaimer: All content is provided solely for academic education and professional pharmacy reference and does not substitute for patient-specific clinical judgement or official CDSCO prescribing information.